Two distinct clinical types of interstitial lung disease associated with polymyositis-dermatomyositis

Respiratory Medicine

Volumn 101, Issue 8, 2007, Pages 1761-1769

  Won Huh, Jin ^a   Soon Kim, Dong ^a   Keun Lee, Chang ^b   Yoo, Bin ^b   Bum Seo, Joon ^b   Kitaichi, Masanori ^c   Colby, Thomas V ^d  

^a Asan Medical Center   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c KYOTO UNIVERSITY HOSPITAL   (Japan)

^d MAYO CLINIC   (United States)

Author keywords

Acute ILD; HRCT; Interstitial lung disease; Polymyositis dermatomyositis; Prognosis

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; STEROID;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEATH; DERMATOMYOSITIS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG MEGADOSE; DYSPNEA; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOXEMIA; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; KOREA; LUNG BIOPSY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; POLYMYOSITIS; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; THORAX RADIOGRAPHY;

ADULT; DERMATOMYOSITIS; FEMALE; HUMANS; KOREA; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34250624547     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.02.017     Document Type: Article

References (63)

1. Nicholson A.G., Colby T.V., and Wells A.U. Histopathological approach to patterns of interstitial pneumonia in patient with connective tissue disorders. Sarcoidosis Vasc Diffuse Lung Dis 19 (2002) 10-17
2. Ito I., Nagai S., Kitaichi M., et al. Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med 171 (2005) 632-638
3. Lee H.K., Kim D.S., Yoo B., et al. Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest 127 (2005) 2019-2027
4. Wiedemann H.P., and Matthay R.A. Pulmonary manifestations of the collagen vascular diseases. Clin Chest Med 10 (1989) 677-722
5. Fujita J., Yoshinouchi T., Ohtsuki Y., et al. Non-specific interstitial pneumonia as pulmonary involvement of systemic sclerosis. Ann Rheum Dis 60 (2001) 281-283
6. Lamblin C., Bergoin C., Saelens T., and Wallaert B. Interstitial lung diseases in collagen vascular diseases. Eur Respir J Suppl 32 (2001) 69s-80s
7. Hunninghake G.W., and Fauci A.S. Pulmonary involvement in the collagen vascular diseases. Am Rev Respir Dis 119 (1979) 471-503
8. Agusti C., Xaubet A., Roca J., Agusti A.G., and Rodriguez-Roisin R. Interstitial pulmonary fibrosis with and without associated collagen vascular disease: results of a two year follow up. Thorax 47 (1992) 1035-1040
9. Wells A.U., Cullinan P., Hansell D.M., et al. Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 149 (1994) 1583-1590
10. Flaherty K.R., Colby T.V., Travis W.D., et al. Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease. Am J Respir Crit Care Med 167 (2003) 1410-1415
11. Papiris S.A., Vlachoyiannopoulos P.G., Maniati M.A., Karakostas K.X., Constantopoulos S.H., and Moutsopoulos H.H. Idiopathic pulmonary fibrosis and pulmonary fibrosis in diffuse systemic sclerosis: two fibroses with different prognoses. Respiration 64 (1997) 81-85
12. Selva-Ocallaghan A., Labrador-Horrillo M., Munoz-Gall X., et al. Polymyositis/dermatomyositis-associated lung disease: analysis of a series of 81 patients. Lupus 14 (2005) 534-542
13. Tazelaar H.D., Viggiano R.W., Pickersgill J., and Colby T.V. Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis 141 (1990) 727-733
14. Ito M., Kaise S., Suzuki S., et al. Clinico-laboratory characteristics of patients with dermatomyositis accompanied by rapidly progressive interstitial lung disease. Clin Rheumatol 18 (1999) 462-467
15. Benbassat J., Gefel D., Larholt K., Sukenik S., Morgenstern V., and Zlotnick A. Prognostic factors in polymyositis/dermatomyositis. A computer-assisted analysis of ninety-two cases. Arthritis Rheum 28 (1985) 249-255
16. Medsger Jr. T.A., Robinson H., and Masi A.T. Factors affecting survivorship in polymyositis. A life-table study of 124 patients. Arthritis Rheum 14 (1971) 249-258
17. Kim D.S., Yoo B., Lee J.S., et al. The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 19 (2002) 121-127
18. Bouros D., Wells A.U., Nicholson A.G., et al. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 165 (2002) 1581-1586
19. Douglas W.W., Tazelaar H.D., Hartman T.E., et al. Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 164 (2001) 1182-1185
20. Cottin V., Thivolet-Bejui F., Reynaud-Gaubert M., et al. Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis. Eur Respir J 22 (2003) 245-250
21. Bohan A., and Peter J.B. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292 (1975) 403-407
22. Bohan A., and Peter J.B. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292 (1975) 344-347
23. Fathi M., and Lundberg I.E. Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol 17 (2005) 701-706
24. Bouros D., Nicholson A.C., Polychronopoulos V., and du Bois R.M. Acute interstitial pneumonia. Eur Respir J 15 (2000) 412-418
25. Al-Hameed F.M., and Sharma S. Outcome of patients admitted to the intensive care unit for acute exacerbation of idiopathic pulmonary fibrosis. Can Respir J 11 (2004) 117-122
26. Bernard G.R., Artigas A., Brigham K.L., et al. The American-European Consensus Conference on ARDS definitions, mechanisms, relevant outcomes, and clinica trial coordination. Am J Respir Crit Care Med 149 (1994) 818-824
27. Ryu J.H., Olson E.J., Midthun D.E., and Swensen S.J. Diagnostic approach to the patient with diffuse lung disease. Mayo Clin Proc 77 (2002) 1221-1227 [quiz 1227]
28. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002;165:277-304.
29. Morris J.F. Spirometry in the evaluation of pulmonary function. West J Med 125 (1976) 110-118
30. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 161 (2000) 646-664
31. Katzenstein A.L., and Myers J.L. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 157 (1998) 1301-1315
32. Muir T.E., Tazelaar H.D., Colby T.V., and Myers J.L. Organizing diffuse alveolar damage associated with progressive systemic sclerosis. Mayo Clin Proc 72 (1997) 639-642
33. Yousem S.A., Colby T.V., and Carrington C.B. Lung biopsy in rheumatoid arthritis. Am Rev Respir Dis 131 (1985) 770-777
34. Schurawitzki H., Stiglbauer R., Graninger W., et al. Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography. Radiology 176 (1990) 755-759
35. Fujii M., Adachi S., Shimizu T., Hirota S., Sako M., and Kono M. Interstitial lung disease in rheumatoid arthritis:assessment with high-resolution computed tomography. Thorac Imaging 8 (1993) 54-62
36. Schwarz MI. The lung in polymyositis. Clin Chest Med 1998;19(8): 701-12.
37. Marie I., Hatron P.Y., Hachulla E., Wallaert B., Michon-Pasturel U., and Devulder B. Pulmonary involvement in polymyositis and in dermatomyositis. J Rheumatol 25 (1998) 1336-1343
38. Schnabel A., Reuter M., Biederer J., Richter C., and Gross W.L. Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment. Semin Arthritis Rheum 32 (2003) 273-284
39. Daniil Z.D., Gilchrist F.C., Nicholson A.G., et al. A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 160 (1999) 899-905
40. Bjoraker J.A., Ryu J.H., Edwin M.K., et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 157 (1998) 199-203
41. Nagai S., Kitaichi M., Itoh H., Nishimura K., Izumi T., and Colby T.V. Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur Respir J 12 (1998) 1010-1019
42. Travis W.D., Matsui K., Moss J., and Ferrans V.J. Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol 24 (2000) 19-33
43. Jegal Y., Kim D.S., Shim T.S., et al. Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia. Am J Respir Crit Care Med 171 (2005) 639-644
44. Flaherty K.R., Thwaite E.L., Kazerooni E.A., et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax 58 (2003) 143-148
45. Collard H.R., King Jr. T.E., Bartelson B.B., Vourlekis J.S., Schwarz M.I., and Brown K.K. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 168 (2003) 538-542
46. Nicholson A.G., Colby T.V., du Bois R.M., Hansell D.M., and Wells A.U. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 162 (2000) 2213-2217
47. Flaherty K.R., Toews G.B., Travis W.D., et al. Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J 19 (2002) 275-283
48. Strimlan C.V., Rosenow III E.C., Weiland L.H., and Brown L.R. Lymphocytic interstitial pneumonitis. Review of 13 cases. Ann Intern Med 88 (1978) 616-621
49. Yousem S.A., Colby T.V., and Carrington C.B. Follicular bronchitis/bronchiolitis. Hum Pathol 16 (1985) 700-706
50. Kameda H., Nagasawa H., Ogawa H., et al. Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis. J Rheumatol 32 (2005) 1719-1726
51. Miyazaki E., Ando M., Muramatsu T., et al. Early assessment of rapidly progressive interstitial pneumonia associated with amyopathic dermatomyositis. Clin Rheumatol (2005) 1-4
52. Marie I., Hachulla E., Cherin P., et al. Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum 47 (2002) 614-622
53. Shinohara T., Hidaka T., Matsuki Y., et al. Rapidly progressive interstitial lung disease associated with dermatomyositis responding to intravenous cyclophosphamide pulse therapy. Intern Med 36 (1997) 519-523
54. Akira M., Hara H., and Sakatani M. Interstitial lung disease in association with polymyositis-dermatomyositis: long-term follow-up CT evaluation in seven patients. Radiology 210 (1999) 333-338
55. Ikezoe J., Johkoh T., Kohno N., Takeuchi N., Ichikado K., and Nakamura H. High- resolution CT findings of lung disease in patients with polymyositis and dermatomyositis. J Thorac Imaging 11 (1996) 250-259
56. Mino M., Noma S., Taguchi Y., Tomii K., Kohri Y., and Oida K. Pulmonary involvement in polymyositis and dermatomyositis: sequential evaluation with CT. AJR Am J Roentgenol 169 (1997) 83-87
57. Schwarz M.I., Matthay R.A., Sahn S.A., Stanford R.E., Marmorstein B.L., and Scheinhorn D.J. Interstitial lung disease in polymyositis and dermatomyositis: analysis of six cases and review of the literature. Medicine (Baltimore) 55 (1976) 89-104
58. Schwarz M.I. Pulmonary and cardiac manifestations of polymyositis-dermatomyositis. J Thorac Imaging 7 (1992) 46-54
59. Fudman E.J., and Schnitzer T.J. Dermatomyositis without creatine kinase elevation. A poor prognostic sign. Am J Med 80 (1986) 329-332
60. Kashiwabara K., and Ota K. Rapidly progressive interstitial lung disease in a dermatomyositis patient with high levels of creatine phosphokinase, severe muscle symptoms and positive anti-Jo-1 antibody. Intern Med 41 (2002) 584-588
61. al-Janadi M., Smith C.D., and Karsh J. Cyclophosphamide treatment of interstitial pulmonary fibrosis in polymyositis/dermatomyositis. J Rheumatol 16 (1989) 1592-1596
62. Schnabel A., Hellmich B., and Gross W.L. Interstitial lung disease in polymyositis and dermatomyositis. Curr Rheumatol Rep 7 (2005) 99-105
63. Ochi S., Nanki T., Takada K., et al. Favorable outcomes with tacrolimus in two patients with refractory interstitial lung disease associated with polymyositis/dermatomyositis. Clin Exp Rheumatol 23 (2005) 707-710